Pacira BioSciences News

Pacira BioSciences Analyst Ratings

BenzingaApr 9 06:15 ET

Teva Upgraded at J.P. Morgan on Upcoming Catalysts

Seeking AlphaMar 8 10:21 ET

Pacira BioSciences Analyst Ratings

BenzingaMar 7 05:00 ET

Pacira BioSciences Analyst Ratings

BenzingaMar 4 07:01 ET

RBC Cuts Price Target on Pacira BioSciences to $45 From $53, Keeps Outperform Rating

MT NewswiresMar 1 08:08 ET

Pacira BioSciences Analyst Ratings

BenzingaMar 1 05:28 ET

Pacira BioSciences Analyst Ratings

BenzingaFeb 8 08:30 ET

RBC Cuts Price Target on Pacira BioSciences to $53 From $58, Keeps Outperform Rating

MT NewswiresJan 3 08:06 ET

Raymond James Initiates Coverage On Pacira BioSciences With Outperform Rating, Announces Price Target of $42

BenzingaDec 20, 2023 06:31 ET

Pacira BioSciences Analyst Ratings

BenzingaDec 20, 2023 06:30 ET

HC Wainwright & Co. Maintains Buy on Pacira BioSciences, Lowers Price Target to $57

BenzingaNov 6, 2023 06:32 ET

Pacira BioSciences Analyst Ratings

BenzingaNov 3, 2023 15:14 ET

RBC Cuts Price Target on Pacira BioSciences to $58 From $67, Keeps Outperform Rating

MT NewswiresNov 3, 2023 08:05 ET

Needham Maintains Buy on Pacira BioSciences, Lowers Price Target to $45

BenzingaNov 3, 2023 06:42 ET

Pacira BioSciences Analyst Ratings

BenzingaNov 3, 2023 06:40 ET

Pacira BioSciences Analyst Ratings

BenzingaOct 23, 2023 10:43 ET

RBC Capital Reiterates Outperform on Pacira BioSciences, Maintains $68 Price Target

BenzingaOct 3, 2023 10:57 ET

Pacira BioSciences Analyst Ratings

BenzingaOct 3, 2023 10:56 ET

Wedbush Lowers Pacira BioSciences' Price Target to $57 From $60, Keeps Outperform Rating

MT NewswiresAug 4, 2023 07:07 ET

Truist Securities Maintains Buy on Pacira BioSciences, Lowers Price Target to $55

BenzingaAug 3, 2023 12:10 ET